Browse Tag

lilly q3

Lilly announced third-quarter earnings

1 min read

The FINANCIAL — Lilly reported Q3 financial results:  – Revenue in the third quarter of 2020 increased 5 percent driven by volume growth of 9 percent, while on a year-to-date basis revenue increased 6 percent driven by volume growth of 12 percent. – Key growth products launched since 2014, consisting of Taltz, Trulicity, Verzenio, Jardiance, Olumiant, Emgality, Tyvyt, Baqsimi, Cyramza, Retevmo and Basaglar contributed nearly 9 percentage points of revenue growth and represented approximately 52 percent of total revenue for the quarter. – Lilly continues to rapidly advance the development of potential therapeutics for the treatment of COVID-19 and has…

Read More »

Lilly announced third-quarter earnings

1 min read

The FINANCIAL — Lilly reported Q3 financial results:  – Revenue in the third quarter of 2020 increased 5 percent driven by volume growth of 9 percent, while on a year-to-date basis revenue increased 6 percent driven by volume growth of 12 percent. – Key growth products launched since 2014, consisting of Taltz, Trulicity, Verzenio, Jardiance,…